Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00772499 · ClinicalTrials.gov registry record · Phase 4
Vascular Improvement With Olmesartan Medoxomil Study
A Phase 4 study, sponsored by Daiichi Sankyo.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
NCT00772499: Completed Phase 4 study, sponsored by Daiichi Sankyo.
NCT00772499 is a Phase 4 study that has completed, run by Daiichi Sankyo. The registered enrollment target is 100 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00772499, a Phase 4 study, has completed, sponsored by Daiichi Sankyo.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to compare in patients with primary hypertension, the non-blood pressure lowering effects of one-year therapy with olmesartan medoxomil vs. those of atenolol on changes in the vascular structure and function.
Interventions
- DRUG olmesartan medoxomil + hydrochlorothiazide + amlodipine + hydralazine if necessary to control blood pressure
- DRUG atenolol+ hydrochlorothiazide + amlodipine + hydralazine if necessary to control blood pressure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2002-11 |
| Est. Completion | 2005-07 |
| Phase | Phase 4 |
What the finished NCT00772499 record still lists
NCT00772499 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 2 interventions - of which olmesartan medoxomil + hydrochlorothiazide + amlodipine + hydralazine if necessary to control blood pressure is the first listed.
NCT00772499 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00772499 about?
NCT00772499 is a clinical study titled "Vascular Improvement With Olmesartan Medoxomil Study". The purpose of this study is to compare in patients with primary hypertension, the non-blood pressure lowering effects of one-year therapy with olmesartan medoxomil vs. those of atenolol on changes in the vascular structure and function.
What is the current status of trial NCT00772499?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2002-11. Estimated completion is 2005-07.
What interventions are being tested in trial NCT00772499?
The interventions under investigation include: olmesartan medoxomil + hydrochlorothiazide + amlodipine + hydralazine if necessary to control blood pressure (DRUG), atenolol+ hydrochlorothiazide + amlodipine + hydralazine if necessary to control blood pressure (DRUG).
Who is sponsoring clinical trial NCT00772499?
This trial is sponsored by Daiichi Sankyo, which has 236 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00772499's enrollment target sits among peer trials
100 770th of 2000 higher than 1,148 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia